AbbVie, Genomics Medicine Ireland and WuXi NextCODE have joined forces for a 15-year research partnership, investigating therapies for chronic diseases. The 15-year collaboration will focus on major chronic diseases, key to the health of both constituents in Ireland as well as the wider world. AbbVie will use the research database developed by GMI to identify new molecular approaches for therapeutic drug discovery and development as well as to develop companion diagnostics.